OC50.F

Healthcare Medical Devices

Cochlear Limited

€40.00

-0.20 -0.50% today

Price History

Not enough data

Key Stats

Market Cap

5.23B

Avg Volume

P/E (TTM)

61.54

EPS

€0.65

52W High

€83.00

52W Low

€20.00

Div. Yield

8.6%

Valuation

P/B Ratio

4.88

EV/EBITDA

11.01

EV/Revenue

2.25

Margins

Gross Margin 70.7%

Operating Margin 14.3%

Net Margin 6.3%

EBITDA Margin 20.4%

Growth & Returns

Revenue Growth (YoY)

0.8%

Return on Equity

8.0%

Return on Assets

9.7%

Liquidity & Leverage

Current Ratio

2.15

Quick Ratio

1.24

Debt / Equity

0.12

Total Cash

187.70M

Total Debt

212.70M

About

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.